ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.33
0.42%
US Tech 100
21,108.40
1.14%
S&P 500
6,049.24
0.88%
US Dollar vs CAD
1.43342
-0.07%
Bitcoin
105,759.91
-0.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Sanofi (SAN) Share Price

Sanofi

Sanofi (SAN)

Sagalio Energy Ltd
Sant Uk.10te%
Banco Santander SA
99.02
0.17
(0.17%)
Closed January 21 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
99.02
Bid
99.01
Ask
99.40
Volume
1,327,488
98.24 Day's Range 99.59
84.93 52 Week Range 106.14
Market Cap
124.036B
Previous Close
98.85
Open
98.43
Last Trade
104
@
99.02
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,556,636
Shares Outstanding
1,252,640,466
Dividend Yield
11.19%
PE Ratio
22.97
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
www.sanofi.com
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 98.85 €. Over the last year, Sanofi shares have traded in a share price range of 84.93 € to 106.14 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 123.82 € billion. Sanofi has a price to earnings ratio (PE ratio) of 22.97.

Ask ADVFN Intelligence (AI)

SAN Latest News

More News

Communiqué de presse : Opella : étape clé franchie pour l’étude consacrée au Cialis

Communiqué de presse : Opella : étape clé franchie pour l’étude consacrée au Cialis Opella : étape clé franchie pour l’étude consacrée au Cialis Paris, le 21 janvier 2025. Opella, l’activité Santé...

23 hours ago
UK Regulatory

Press Release: Opella reaches study milestone for Cialis

Press Release: Opella reaches study milestone for Cialis   Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US...

23 hours ago
UK Regulatory

Press Release: Opella reaches study milestone for Cialis

  Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical...

23 hours ago
GlobeNewswire Inc.

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...

January 15 2025
UK Regulatory

Sanofi: Information concerning the total number of voting rights and shares – November 2024

Sanofi: Information concerning the total number of voting rights and shares – November 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

January 15 2025
UK Regulatory

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma Approval based on positive pivotal ICARIA-MM phase 3 study using the...

January 13 2025
GlobeNewswire Inc.

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

January 09 2025
UK Regulatory

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sarclisa SC formulation added to Pd for the treatment of R/R MM met the co-primary...

January 09 2025
GlobeNewswire Inc.

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

January 09 2025
UK Regulatory

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Pneumococcal disease remains a major global health...

December 23 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.743.9252728799395.28100.1293.06182398596.90483083DE
46.16.5647869134792.92100.1291.75131960395.54316318DE
12-2.08-2.05736894164101.1101.987.5155663693.57151419DE
265.826.2446351931393.2106.1487.5149403097.19743119DE
525.315.6664176715493.71106.1484.93146455793.40301174DE
1566.897.4785629002592.13106.6676.45173664192.81921852DE
2607.227.8649237472891.8106.6667.65193340989.44542746DE

SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 99.02 €
How many Sanofi shares are in issue?
Sanofi has 1,252,640,466 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 123.82B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 84.93 € to 106.14 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 22.97
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 2.88
What is the reporting currency for Sanofi?
Sanofi reports financial results in EUR
What is the latest annual turnover for Sanofi?
The latest annual turnover of Sanofi is EUR 43.07B
What is the latest annual profit for Sanofi?
The latest annual profit of Sanofi is EUR 5.4B
What is the registered address of Sanofi?
The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DMSBSDiagnostic Medical Systems
0.007 €
(75.00%)
36.27k
POXELPoxel
0.3905 €
(60.04%)
6.13M
GTRDSGroupe Tera DS
0.12 €
(43.71%)
32.95k
MCPGrupo Media Capital Sgps Sa
2.00 €
(23.46%)
5
ALDOLDolfines
4.12 €
(21.00%)
82.74k
DRVDSDrone Volt DS
0.0009 €
(-50.00%)
707.14k
HYPDSHipay Group DS
0.011 €
(-45.00%)
32.76k
NICBSNicox SA
0.0178 €
(-22.61%)
11
ALGENGenoway S A Inh Eo 15
3.06 €
(-19.69%)
123.45k
ALBOOBOOSTHEAT
0.058 €
(-16.91%)
161k
ATOAtos SE
0.0022 €
(10.00%)
3.39B
BCPBanco Comercial Portugues SA
0.5124 €
(1.03%)
79.14M
ALCYBCybergun
0.0001 €
(0.00%)
31.06M
ALVERVergnet
0.0014 €
(-6.67%)
21.7M
EDPEDP SA
3.069 €
(-1.76%)
12.59M

Discussion

View Full Feed
BDEZ BDEZ 3 minutes ago
More illegals on the way...

Despite President Trump taking office, this migrant caravan of 2,000 left Mexico and is making its way to our border!

Columbian Erkin Torres, who’s in the caravan, screams “Trumps actions cannot supersede the United Nations.” He thinks it’s
gfp927z gfp927z 3 minutes ago
Bigworld, Well, so far so good with the stock market. Only one day though, and the big test will come as the Trump's tariff plans are further clarified. One good thing for the bulls is that Trump's ego makes him sensitive to the stock market direction, and he knows that going big on tariffs will
IBIT
dinogreeves dinogreeves 4 minutes ago
What gives, Hydrogen is going to be dead with this administration now in power. More like dead cat bounce. I will stick to what I know. It till cost trillion in infrastructure bill to make this work. I seriously would not waste my time on it. Dead money
GVSI
BottomBounce BottomBounce 4 minutes ago
'Britain's Warren Buffett,' Is Staying Away From Nvidia Stock He manages a nearly $30 billion fund and has chosen not to buy Nvidia shares. $NVDA
NVDA
fuagf fuagf 5 minutes ago
Gawd, i'm not giving him any benefit of any doubt, why would i is right. I never would. As a matter of fact his forgetting, to my mind, was more of a condemnation of him than him not doing it on purpose. That's why i said it. You have it all ass-backwards when it comes to that.
HyphenDubenator HyphenDubenator 5 minutes ago
Defense and Space Company Voyager Technologies Files to Go Public
The sector is expected to benefit under the Trump administration.
WSJ Jan 21, 2025
Defense-and-space company Voyager Technologies has confidentially filed to go public, signaling what could be a busy year for IPO
PLTR
Angelmin Angelmin 5 minutes ago
I think Elon Musk is right about Bessents's nomination for Treasury Secretary. He said Bessent is not a changemaker or a fighter, but follows the businesses as usual.
FNMA
BottomBounce BottomBounce 5 minutes ago
https://www.youtube.com/watch?v=wdvJ0jNqkaw $NVDA
NVDA
SkyLimit2022 SkyLimit2022 6 minutes ago
zero82,

https://investorshub.advfn.com/uimage/uploads/2025/1/21/nntdlgiphy.gif

“Cash attached” will be determined by the combo efficacy in clinical trials. You keep reposting your same baseless argument daily, as if certain corporate players (or market manipulators) can
NWBO
Carjockey2 Carjockey2 6 minutes ago
One of my first posts on 11/10 on $HMBL

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159400428

Hardly looks like front loading in August to me sweetie pie!!

$HMBL

Was a nice pickup for me and a nice run but the next one w
HMBL
Stock_Barber Stock_Barber 7 minutes ago
Everyone is aware...

Is there a single company that you don't hate?

I have NEVER seen you post a single positive thing about any company!
WBA
jay_tee jay_tee 7 minutes ago
Contrary to what you believe FOXO was saved by a no bid em piece of junk.. The irony is mind boggling don't you think? 
FOXO
I ll be back I ll be back 7 minutes ago
Rum, where you been?

While there has been some interesting trading on SRAX, I'm not holding my breath here. On the other hand, it would be worth your time to catch up on and OLD favorite. MGON new management team as pulled off a number of new developments in the last year. They now
MGON
dinogreeves dinogreeves 8 minutes ago
I am on big boards, below is one of them. NBI*S and OS*S are others in the space.

https://robinhood.com/us/en/stocks/SMCI/. Just over $110,000 invested.

TGL*O is my lottery and generational wealth $170,000

George may not be tech guy, in-fact he doesn't n
SMCI TGL
BottomBounce BottomBounce 8 minutes ago
Ballard Power Systems to supply Stadler with fuel cell engines for Californian passenger rail

The eight megawatts FCmove®-HD+ fuel cell engines will be used to power the California Department of Transportation’s zero-emission passenger trains. https://www.masstransitmag.com/rail/vehi
BLDP
LOVELWLG LOVELWLG 8 minutes ago
I guess 7 years of Lebbys dog and pony shows didn't catch anyone's attention.
LWLG
igotthemojo igotthemojo 9 minutes ago
The whole thing is about dilution…
KBLB
igotthemojo igotthemojo 9 minutes ago
If the money came from a reputable financial institution at a decent rate and terms, it would have had given Kblb more credibility…

This deal is dilution with the same hedge fund as before…a little better deal…but the same thing…just different…

I still think it’s a posi
KBLB
janice shell janice shell 10 minutes ago
By the way: the answer to your posting perplexity is simple. Just keep two or more windows open to IHub at all times.
JoJr JoJr 11 minutes ago
They are throwing a desperation party...

I threw my invitation in the trash.
RDAR
Riley4 Riley4 12 minutes ago
Climate change is 100% sun related, please look at 100 yr sea level changes. Pollution is the problem, we need to quit polluting, and maybe alert China, India, and all third world countries.
NWBO
Hawk05 Hawk05 13 minutes ago
New Packaging?

https://www.inishpharmacy.com/p/actipatch-pulse-therapy-musculoskeletal-pain-relief/actipatch-musclejoint
BIEL
Carjockey2 Carjockey2 14 minutes ago
Really..

Hummmm

Why don't you go through my posts and look and see when I actually bought a few months ago and when I started posting here.

I'm sorry if you can't call me at front loader in August I wasn't even here then or September !!!!!!!!
HMBL
Angelmin Angelmin 14 minutes ago
My first impression about Bessent's privatization of F&F is not great. I feel he is a snake like Mnuchin. He just wants a prestige job, not a fighter for GSE. 
FNMA

Your Recent History

EU
SAN
Sanofi
USOTC
NTBLQ
Notable Labs (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads